HbA1c Levels Do Not Affect Long-Term Outcome After Open Trigger Finger Release in Individuals With Diabetes Mellitus
Mattias Rydberg1, Katarina Eeg-Olofsson2,3, Marianne Arner4
1Department of Translational Medicine - Hand Surgery, Lund University, Sweden.
Summary
High hemoglobin A1c (HbA1c) levels did not impact long-term outcomes for patients undergoing open trigger finger release (OTFR) surgery. Glycemic control did not affect patient-reported outcomes 12 months post-surgery in individuals with diabetes mellitus.
Area of Science:
- Orthopedic Surgery
- Endocrinology
- Diabetes Mellitus Research
Background:
- Open trigger finger release (OTFR) surgery generally yields successful outcomes, even in patients with diabetes mellitus (DM).
- The influence of glycemic control on long-term results after OTFR in diabetic patients remains under investigation.
- This study specifically investigates the impact of elevated hemoglobin A1c (HbA1c) levels on patient-reported outcomes (PROs) following OTFR in individuals with type 1 (T1DM) and type 2 diabetes mellitus (T2DM).
Purpose of the Study:
- To determine if high HbA1c levels affect patient-reported outcomes after open trigger finger release (OTFR) surgery.
- To analyze the association between glycemic control (HbA1c levels) and long-term functional outcomes (QuickDASH, HQ-8) in diabetic patients undergoing OTFR.
- To assess the necessity of preoperative HbA1c testing for predicting long-term results of OTFR in patients with T1DM and T2DM.
Main Methods:
- Retrospective analysis of data from 2010-2020 from the Swedish hand surgery quality register (HAKIR) and the Swedish National Diabetes Register.
- Inclusion of adult patients (≥18 years) who underwent OTFR, stratified into tertiles based on mean HbA1c: optimal (≤48 mmol/mol), acceptable (48.1-64 mmol/mol), and poor (>64 mmol/mol).
- Assessment of PROs using QuickDASH and HQ-8 questionnaires at pre-operative, 3-month, and 12-month follow-ups; statistical analysis using adjusted linear mixed-model regression and Bonferroni correction.
Main Results:
- A total of 496 individuals with T1DM and 869 with T2DM underwent OTFR; 53% (n=710) completed at least one questionnaire.
- No statistically significant differences in QuickDASH or HQ-8 scores were observed at 12 months between the different HbA1c control groups for either T1DM or T2DM patients.
- The findings indicate that glycemic control, as measured by HbA1c levels, did not influence patient-reported outcomes 12 months after OTFR.
Conclusions:
- Poor glycemic control was not associated with adverse long-term patient-reported outcomes following open trigger finger release (OTFR).
- Preoperative HbA1c testing does not appear necessary for predicting the long-term success of OTFR in patients with diabetes mellitus.
- These results suggest that diabetic patients can expect similar functional recovery after OTFR regardless of their glycemic control status.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
2.7K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K
Diabetes Mellitus: Type 2 and Gestational
5.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
Carbohydrate Metabolism
14.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.8K
Diabetes Mellitus: Overview and Type I Subtype
5.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.8K
Diabetes: Management and Pharmacotherapy
1.3K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.3K
Hypoglycemia and Glucagon
1.2K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.2K


